Weaver C. Barksdale & Associates Inc. Has $1.44 Million Position in Omega Healthcare Investors Inc (OHI)

Weaver C. Barksdale & Associates Inc. grew its position in Omega Healthcare Investors Inc (NYSE:OHI) by 77.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 52,210 shares of the real estate investment trust’s stock after purchasing an additional 22,743 shares during the period. Weaver C. Barksdale & Associates Inc.’s holdings in Omega Healthcare Investors were worth $1,438,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in OHI. Barnett & Company Inc. boosted its position in Omega Healthcare Investors by 1,980.0% during the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock worth $166,000 after purchasing an additional 4,950 shares in the last quarter. Mcmillion Capital Management Inc. purchased a new position in Omega Healthcare Investors during the third quarter worth approximately $201,000. Timber Hill LLC purchased a new position in Omega Healthcare Investors during the third quarter worth approximately $206,000. Good Life Advisors LLC purchased a new position in Omega Healthcare Investors during the third quarter worth approximately $209,000. Finally, HighPoint Advisor Group LLC purchased a new position in Omega Healthcare Investors during the third quarter worth approximately $216,000. 68.07% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Bernard J. Korman acquired 100,000 shares of the company’s stock in a transaction dated Friday, December 22nd. The stock was acquired at an average cost of $26.89 per share, with a total value of $2,689,000.00. Following the completion of the purchase, the director now owns 896,895 shares of the company’s stock, valued at approximately $24,117,506.55. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig R. Callen acquired 10,000 shares of the company’s stock in a transaction dated Thursday, November 2nd. The stock was purchased at an average cost of $27.38 per share, with a total value of $273,800.00. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 210,000 shares of company stock valued at $5,786,800. 1.54% of the stock is owned by insiders.

Shares of Omega Healthcare Investors Inc (OHI) traded down $0.01 during trading on Wednesday, reaching $26.11. The company had a trading volume of 1,869,400 shares, compared to its average volume of 1,988,360. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.40 and a current ratio of 3.40. The stock has a market capitalization of $5,250.00, a P/E ratio of 34.36, a price-to-earnings-growth ratio of 2.70 and a beta of 0.49. Omega Healthcare Investors Inc has a 52-week low of $26.06 and a 52-week high of $35.14.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Monday, October 30th. The real estate investment trust reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.83 by ($1.50). Omega Healthcare Investors had a return on equity of 3.92% and a net margin of 17.61%. equities analysts predict that Omega Healthcare Investors Inc will post 3.21 EPS for the current fiscal year.

Several equities analysts have recently weighed in on the company. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Friday, November 3rd. Hilliard Lyons downgraded Omega Healthcare Investors to a “buy” rating in a research report on Wednesday, November 1st. Vetr downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $32.96 target price on the stock. in a research report on Monday, October 30th. Stifel Nicolaus downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating and decreased their target price for the company from $35.00 to $29.00 in a research report on Tuesday, October 31st. Finally, TheStreet downgraded Omega Healthcare Investors from a “b-” rating to a “c” rating in a research report on Monday, October 30th. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $32.14.

WARNING: This piece was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://ledgergazette.com/2018/01/17/weaver-c-barksdale-associates-inc-increases-position-in-omega-healthcare-investors-inc-ohi.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply